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Silks are protein-based ﬁbers made by arthropods for a variety of task-speciﬁc applications. In this article,
we review the key features of silk proteins. This article initially focuses on the structure and function of
silk proteins produced naturally by silkworms and spiders, followed by the biological and technical
processing of silk proteins into a variety of morphologies (including capsules, ﬁbers, ﬁlms, foams, gels
and spheres). Finally, we highlight the potential applications of silk-based materials.
 2008 Elsevier Ltd. Open access under CC BY-NC-ND license.1. Introduction – nature’s biopolymers
Biopolymers such as polyamino acids, polynucleic acids, poly-
phenols and polysaccharides have evolved over billions of years to
carry out a myriad of tasks such as catalysis, molecular recognition
or the storage of energy or information. Biopolymers are synthe-
sized from a very limited number of building blocks and it is their
complex three-dimensional structures that are responsible for their
highly specialized properties [1–3].
Polyamino acids and polynucleic acids are synthesized in
template-directed catalyzed reactions yielding monodisperse
linear polymers composed of a speciﬁc sequence of monomers;
whereas polyphenols and polysaccharides are prepared via
untemplated catalyzed reactions yielding polydisperse polymers
with a wide variety of potential structures (including linear and
branched) depending upon the monomers involved [4–9].
Biopolymers are commonly occurring structural elements of
biological systems. Polysaccharides are the most abundant biopoly-
mers on earth, cellulose and chitin serve as structural elements in
plant cellwalls andanimal exoskeletons; polyphenols such as lignins
are important structural elements in wood and other plants; and
polyamino acids such as collagen and elastin are the main compo-
nents of blood vessels, connective tissues and skins in animals and
humans [4,5,9–20].
Silkworms produce polyamino acid-based (silk protein) cocoons
to protect themselves during their metamorphosis into moths, and
humans have harvested silk ﬁbers from these cocoons for centuriesþ49 921557346.
(T.R. Scheibel).
-NC-ND license.to produce textiles due to their characteristic luster, moisture
absorbance and strength [21,22]. Web-weaving spiders produce
silk-based webs (from a variety of different silk protein-based
ﬁbers) to capture prey; certain of these silk ﬁbers have mechanical
properties surpassing Nylon, Kevlar, silkworm silk, and high-tensile
steel [23–26], as summarized in Table 1 [27]. In this article, we will
focus on materials derived from silk proteins produced by silk-
worms and spiders.
1.1. Protein characteristics and structure
Polyamino acids (known as polypeptides or proteins) in higher
organisms are synthesized from combinations of up to 19 amino
acid monomers (–NH–CHR1–CO–) and 1 imino acid monomer
(–NR1–CHR2–CO–), linked via amide bonds (also known as peptide
bonds) between the monomers (which are more commonly
referred to as residues). In higher organisms, only the L-amino acids
are used as monomers, whereas in lower life forms (such as
bacteria or lower plants) D-amino acid monomers can also be
incorporated [8,28,29].
In vivo, polyamino acids are synthesized in a template-directed
fashion: ﬁrst, DNA is used as a template in the synthesis of
messenger RNA (mRNA) via a process known as transcription;
mRNA can subsequently be used as a template by ribosomes in the
synthesis of a sequence-speciﬁc polypeptide, this process is known
as translation, because the information stored in a polynucleic acid
(genetic code) is translated into information in a polyamino acid
(functional code) [30,31].
The sequence of residues in the polypeptide is known as the
primary structure. The amino acid residues display different func-
tional groups on the polyamide backbone of the polymer; these
functional groups can be categorized as polar, non-polar, aromatic,
Table 1
Mechanical properties of silk and man-made ﬁbers
Material Strength, smax/GPa Extensibility, 3max Toughness/MJm
3
B. mori silk 0.6 0.18 70
A. diadematus MA silk 1.1 0.27 160
A. diadematus Flag silk 0.5 2.70 150
Nylon 0.95 0.18 80
Kevlar 49 3.6 0.027 50
High-tensile steel 1.5 0.008 6
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interactions (such as hydrogen bonding between the amide bonds
in the backbone of the polymer, or p interactions between aromatic
groups) determine the local conformation of the polypeptidewhich
is known as the secondary structure – prominent examples of
common secondary structures are: a-helices, b-sheets and b-turns
(see Fig. 1) [2,32].
Hydrogen bonds between the hydrogen atom attached to the
nitrogen atom of an amide and the carbonyl oxygen atom of the
fourth amino acid on the amino-terminal side of the peptide bond
encourage the polymer to coil around an axis into an a-helix; each
helical twist contains on average 3.6 amino acids and is 5.4 Å in
length. a-Helix formation is encouraged by ion pair formation
between oppositely charged residues 3 or 4 amino acids apart, and
p-interactions between similarly spaced aromatic amino acids
[2,32]. Less common are helical twists containing 3 amino acids
(known as 31- or 310-helice [33,34]) which are important in some
silk proteins [35–37].
In certain cases, hydrogen bonding between chains (intrachain
or interchain) that are side by side causes the polypeptide chain to
adopt a zigzag conformation, known as a b-sheet. Amino acids with
small side chains such as glycine and alanine allow stacking of
b-sheets, whereas bulkier amino acids discourage this sort of
assembly process [2].
Turns and loops are also frequently occurring secondary
structures in polypeptides. Particularly common are 180 loops,
known as b-turns, which consist of 4 amino acids where the
carbonyl oxygen of the ﬁrst amino acid is hydrogen bonded to
the hydrogen on the amine of the fourth amino acid. Importantly,
the second and third amino acids do not participate in hydrogen
bonding [32].
Polypeptides therefore contain regions that are either locally
disorganized or locally organized dependent upon their primary
structure, and covalent or non-covalent cross-links between
different regions within a polypeptide chain determine the overall
three-dimensional arrangement of the polypeptide chain, which is
known as the tertiary structure. Further interactions (covalent or
non-covalent) between individual polypeptide chains (identical or
different) determine a protein’s quaternary structure [3,38].
The process by which polypeptides assume their secondary,
tertiary and quaternary structures after polymerization is known as
‘folding’ [38,39] and is in some cases aided by accessory proteins.
Once the process of folding is complete and the polypeptides are
fully assembled into their biologically active conformations, the
polypeptides are said to be in their ‘native’ state [39].unfolded α-helix 310-hel
Fig. 1. Common secondary stru1.2. Silk proteins – structure and hierarchical assembly
Silks are protein-based ﬁbers made by arthropods for a variety
of task-speciﬁc applications. Silk ﬁbers are typically composite
materials formed of silk protein and other associated molecules
such as glycoproteins and lipids [40–44].
1.2.1. Silkworm silk
Of all natural silk-producing animals, mulberry silkworms
(Bombyx mori) are of the most economic importance, because it is
possible to rear them in captivity. After the eggs laid by adult moths
hatch, the caterpillars are fed fresh mulberry leaves for a month
until they are mature enough for metamorphosis into a moth,
which requires the construction of a protective cocoon of silk [45–
48]. Once the cocoon is complete, silk farmers kill the caterpillar via
exposure to hot water/steam, and the silk can be harvested. The
crude silk needs both degumming [49–53] (from the glue-like
sericin) and processing before it can be dyed and sold.
The fact that there is a readily available source of silkworm silk
has facilitated an understanding of its structure and function
[22,44,54,55]. B. mori silk has a core–shell type structure, with its
core composed of a complex of 3 proteinaceous components:
a large protein, known as heavy chain ﬁbroin (H-chain, ca. 350 kDa)
that is linked to a second small protein, known as light chain ﬁbroin
(L-chain, ca. 25 kDa) via disulﬁde bonds; and a third small glyco-
protein, known as the P25 protein (P25, ca. 30 kDa) is associated via
non-covalent hydrophobic interactions [56–58]. The molar ratios of
H-chain:L-chain:P25 are 6:6:1; the H-chain is hydrophobic and
provides crystalline like features to the silk thread, whereas the
L-chain is more hydrophilic and relatively elastic, and the P25
protein is believed to play a role in maintaining the integrity of the
complex [56–59]. Before ﬁber formation, a solution of the three
proteins is secreted from two glands within the silkworm, assem-
bling into twin ﬁlaments that emerge from an exit tube in its head
(known as the spinneret) and dry upon exposure to air. The
resulting core contains anisotropic b-sheet-rich nanocrystals
that are loosely aligned with the ﬁber axis and dispersed in an
unstructured matrix [21,54,55,59,60]. Another pair of glands
secretes glue-like sericins [61–64] (a set of serine-rich glycopro-
teins) that coat the ﬁbroin ﬁlaments and ensures the cohesion of
the cocoon by sticking the twin ﬁlaments together. Finally the ﬁber
is coated with a variety of other proteins postulated to protect the
cocoon against microbes and predators (see Fig. 2) [65–73].
1.2.2. Spider silks
Spiders have evolved to be able to produce a variety of task-
speciﬁc silks for catching prey (via trapdoors and webs), protection
and preservation of their offspring and prey (in cocoon-like struc-
tures), as a lifeline to escape from predators and even as a means of
transport (parachute-like structures) [23,74–81].
More than 34,000 different species of spiders have been iden-
tiﬁed, of which approximately half catch their prey in webs (of
which there are over 130 catalogued designs). Orb webs are
a particularly interesting example of web design and they are
constructed from four different types of task-speciﬁc silks (see
below) [23,24,76,82,83].ß-sheet ß-turnix
ctural motifs in proteins.
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Fig. 2. Examples of silk ﬁbers produced by silkworms and spiders and a schematic illustration.
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large scale due to their cannibalistic nature, therefore spider silks
are typically obtained via harvesting of the silk at its point of
application (in the case of spider webs great attention to detail is
required to obtain uncontaminated samples); anaesthetization of
single spiders followed by forcible silking of the spidroin from its
source gland (in the case of major and minor ampullate and
cylindriform silks [84]), or extraction of the spidroin directly from
the gland in which it is produced (after killing the spider) [85].
In order to circumvent such complicated procedures, identiﬁ-
cation of the protein sequences has allowed the recombinant
production of genetically engineered analogues in sufﬁcient yield
and purity for application as high performance biomaterials. A
comprehensive review of these biotechnological developments
was recently published by Vendrely and Scheibel [86].
1.2.2.1. Major ampullate silk. Silk ﬁbers made of proteins produced
in the major ampullate silk gland (MA silk, >300 kDa [87–91])
have a very high-tensile strength (comparable to Kevlar) and
moderate elasticity [27,92–99]. MA silks are used as a scaffold upon
which to attach other silks during the construction of a web and as
a lifeline when it is necessary to escape from a predator [23]. MA
silks have diameters between 1 and 20 mm (depending upon spider
species) and have a core–shell type structure. The core contains two
major proteins (Major Ampullate Spidroins 1 and 2) that are
composed predominantly of glycine, alanine and proline (although
the quantity of the latter varies signiﬁcantly between species)
[85,91,100]. Major ampullate spidroins of Araneus diadematus and
Nephila clavipes spiders are reminiscent of block copolymers
containing blocks of polyalanine and either (GGX)n (where X is
typically tyrosine, leucine or glutamine) or GPGXX [101]. Thealanine-rich blocks are known to form b-sheet stacks [93] that are
responsible for the high-tensile strength of MA silks; whereas the
blocks of (GGX)n presumably form 310-helices [35], and the blocks
of GPGXX form b-turn spirals imparting elasticity/ﬂexibility to the
proteins [102–104]. MA proteins assemble in the spinning duct are
secreted as a solution from a valve located at the end of the spin-
ning duct, and dry upon exposure to air, resulting in a core spidroin
ﬁlament containing isotropic b-sheet-rich nanocrystals dispersed
in a matrix [42–44]. This core ﬁlament is coated in another layer of
MA spidroin-like protein, a glycoprotein coat, and ﬁnally a lipid coat
(see Fig. 2) [40,42–44,105].
1.2.2.2. Minor ampullate silk. Silk ﬁbers made of proteins produced
in the minor ampullate silk gland (MI silk, >250 kDa [89]) have
similar mechanical properties to MA silk, and are used to build
a spiral that temporarily stabilizes the scaffold of the web during its
construction [106–108]. MI silks are also mainly composed of two
major proteins (Minor ampullate spidroins 1 and 2) that are similar
in composition to MA silk, but with two signiﬁcant differences:
ﬁrst there is virtually no proline present in MI silk; and second the
glutamate content is markedly reduced [85]. Minor ampullate
spidroins from A. diadematus and N. clavipes spiders comprise
blocks of polyalanine, (GA)n, (GGX)n, and multiple copies of
a highly conserved serine-rich 130 amino acid non-repetitive
sequence that acts as a spacer, breaking up the repetitive regions
(see Fig. 3) [37,101,108,109].
1.2.2.3. Flagelliform silk. Silk ﬁbesmade of proteins produced in the
ﬂagelliform silk gland (Flag silk, ca. 500 kDa) are highly elastic and
are used to produce the capture spiral [80,101,104,108,110,111]. In
comparison to MA silk, Flag silk is composed of only one major
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reduced amounts of alanine [85]. Flag proteins from N. clavipes
spiders comprising blocks of (GGX)n assumed to form 310-helices;
blocks of GPGXX leading to b-turn spirals imparting elasticity/
ﬂexibility to the proteins [102–104]; and a highly conserved non-
silk-like spacer sequence (such as TIIEDLDITIDGADGPITISEELTI) the
function of which is uncertain, however, its polar hydrophilic
nature may be important for both cross-linking and hydration of
the ﬁber [112].
1.2.2.4. Pyriform silk. The pyriform silk gland produces a sophisti-
cated protein glue (Pyriform silk) that is used to securely attach the
MA scaffold to a substrate (such as trees, walls, etc.), and subse-
quently Flag silk to theMA scaffold [113–115]. Pyriform silk proteins
from A. diadematus spiders contain relatively low amounts of small
non-polar amino acids, signiﬁcant quantities of polar and charged
amino acids (important for cross-linking), and are assumed to be
randomly coiled before and after secretion facilitating the
maximum number of cross-links [85].
1.2.2.5. Aggregate silk. The aggregate silk gland produces
a mixture of sticky glycoproteins and small highly hygroscopic
peptides that are used to coat the capture threads of orb webs
[105,116,117]. Aggregate silk proteins from Latrodectus hesperus
spiders [117] contain relatively low amounts of small non-polar
amino acids, signiﬁcant quantities of proline, and both polar and
charged amino acids that are important for cross-linking and
hydration of the ﬁber [85].
1.2.2.6. Cylindriform/tubuliform silk. Silk ﬁbers made of proteins
produced in the cylindriform/tubuliform silk glands (cylindri-
form/tubuliform silk) are used to produce tough egg case silk [118–
126]. Cylindriform proteins of A. diadematus spiders are composed
of blocks of An and (GGX)n (X¼A, L, Q, or Y) yielding protein
structures rich in b-sheet stacks (similar to major ampullate silk
proteins produced by N. clavipes spiders) [127].elastic
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Fig. 3. Structural motifs occurring within the primary structure of spider silk proteins determ
proteins. The spacer represents non-repetitive but conserved regions that disrupt the glyci1.2.2.7. Aciniform silk. Silk ﬁbers made of proteins produced in the
aciniform silk gland (aciniform silk) serve numerous purposes:
one type is used as a soft lining inside the egg case used for a spi-
der’s offspring, whereas another type is used to reinforce the
pyriform silk cement matrix [128–131]. Studies of the amino acid
contents of aciniform silk from Argiope trifasciata [128] and L.
hesperus [130] spiders indicate the presence of GGX domains in the
proteins, but that they are both notably different from other types
of silk proteins [85].2. Silk protein processing
2.1. Protein solubility
Proteins in aqueous solution tend to be covered by a highly
ordered layer of water (known as the hydration layer), with 10%
greater density and 15% greater heat capacity than that of bulk
water [132–136]. The solubility of a protein in water is affected by
the presence of other solutes such as ions, organic solvents, poly-
mers or surfactants. Low concentrations of salt tend to improve the
solubility of proteins (known as ‘salting in’), due to the formation of
ion-rich hydration layers in the vicinity of charged and polar amino
acid residues (as described by the Debye–Hu¨ckel theory). High
concentrations of salt tend to have the opposite effect, causing the
protein to precipitate (known as ‘salting out’). The magnitude of
this effect is dependent upon the particular ions, and usually
follows the Hofmeister series (see Fig. 4) [132,137–150].
Originally it was thought that an ion’s inﬂuence on the prop-
erties of macromolecules was primarily due to its effects upon bulk
water structure; kosmotropic ions are highly hydrated and were
thought to be ‘water structure makers’ that stabilized protein
structure and salted-out proteins, whereas chaotropic ions were
thought to be ‘water structure breakers’ destabilizing folded
proteins and giving rise to salting-in behavior. More recent studies
demonstrate that although ions interact strongly with water, this isamorphous spacer
spacer
~ 30 aa
ine function
ets
ch
310-helix
GGX
termini
folded
ine their mechanical properties. X indicates a residue that may vary within or between
ne-rich repeats. More details on the motifs can be found in the text.
NH4+
SO42
- HPO42
- acetate- Cl- NO3- ClO4- SCN-I-
K+ Na+ Li+ Mg2+ Ca2+ guanidinium+
salt out (aggregate) salt in (solubilize)
structure denaturation
weak hydrophobic effect
structure stabilization
strong hydrophobic effect
kosmotropic chaotropic
Fig. 4. The Hofmeister series.
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[134,135,140,141,144,145,147,149–154].
As noted above, the presence of both kosmotropic and chao-
tropic ions reduces the hydration of hydrophobic residues causing
the protein to precipitate or ‘salt out’. Furthermore, kosmotropic
anions polarize water molecules that are hydrogen bonded to
amide moieties, thereby reducing hydration of the amide (favoring
‘salting out’), and ﬁnally, chaotropic anions interact directly with
amides (favoring ‘salting in’). This allows the explanation of the
Hofmeister effect by direct ion–macromolecule interactions and
interactions of the ions with water molecules in the ﬁrst hydration
shell of the macromolecule [132,140,141,145,146,149,150].
The pH of the solution also plays a critical role in protein solu-
bility. The isoelectric point (pI) of a protein is the pH at which the
number of positively charged residues is equal to the number of
negatively charged residues. Therefore, if the pH is below the pI the
protein has a net positive charge, if the pH is equal to the pI it has no
net charge, and if the pH is above the pI it has a net negative charge.
The greater the net charge a protein carries, the greater the charge
repulsion between its similarly charged residues and the less
attracted it is to other similarly charged proteins. In cases where the
protein is uncharged it is more prone to aggregation. Also note-
worthy is that most proteins unfold at a certain pH value, which
encourages aggregation due to exposure of hydrophobic residues
[138,148,155–157].
Uncharged solutes also interact with proteins, affecting both
their folding and solubility. Urea is a well-known chaotropic agent,
which at molar concentration interferes with the hydrogen
bonding motifs that stabilize the secondary structure of proteins,
and therefore causes the unfolding of proteins into a random coil
(with protein-dependent effects on solubility) [158,159]. Polymers
such as poly(ethylene glycol) may aid protein crystallization due to
the fact that they restrict the motion of the protein due to volume
exclusion, and that they reduce the hydration of hydrophobic
residues favoring ‘salting out’ [160,161].
Organic solvents also affect the solubility of proteins in water
[162], primarily because charged and ionic residues tend to be less
well solvated by solvents with lower dielectric constants, and also
due to the fact that they interfere with the non-covalent interac-
tions that determine the protein’s secondary structure. Alcohols are
known to both promote and disrupt secondary structure elements
of proteins, but this effect is heavily dependent upon the protein
under investigation: for example triﬂuoroethanol generally stabi-
lizes a-helices at the expense of b-sheets due to its interactionwith
carbonyl oxygen atoms and hydrophobic residues (although certain
investigations withmodel peptides indicateweak interactions with
hydrophobic residues) [163–166]. In contrast, ethanol and meth-
anol promote b-sheet formation at the expense of a-helices due to
dehydration of the a-helices [162]. In certain cases it is possible to
dissolve proteins in non-aqueous solvents, although the fact that
the physical properties (dielectric constant, dipole moment,
hydrophobicity, etc.) of such solvents are different fromwater maysigniﬁcantly affect the folding of the protein due to poor solvation
of the charged and polar regions, favorable solvation of the
hydrophobic regions of the protein and disruption of the hydrogen
bonding patterns [162].
Temperature is another important factor governing the solu-
bility of proteins. Increasing the temperature has two important
effects: ﬁrst, decreasing the order in the structure of water, thereby
decreasing the solvation of the hydrophobic regions of proteins,
and encouraging aggregation through hydrophobic interactions;
and second, unfolding the protein, thus exposing more hydro-
phobic regions to water, which also encourages aggregation
through hydrophobic interactions [140,141,145,146,149].
2.2. Biological processing of silk proteins – ﬁber spinning
The previous section highlighted the environmental conditions
that are important for protein solubility and folding. In this section,
we shall brieﬂy review the folding and ﬁber assembly processes of
major ampullate silks produced from the spidroins of N. clavipes
(MA spidroins 1 and 2) and A. diadematus (ADF-3 and ADF-4)
spiders; which is assumed to be similar to the spinning process for
silkworms (see Fig. 5) [167].
The requisite proteins of individual spider silks are synthesized
in speciﬁc cells and excreted into the lumen of speciﬁc glands, as
described above, for storage (i.e. MA spidroins 1 and 2 are
synthesized in different cells and subsequently excreted into the
lumen of theMA silk gland). MA spidroins are amphiphilic proteins,
composed of repetitive hydrophilic and hydrophobic blocks with
highly conserved non-repetitive polypeptide sequences at the N-
and C-termini. These proteins are stored at remarkably high
concentrations (up to 50% w/v) without the occurrence of unde-
sirable aggregation [35].
The ﬂow of the proteins through a narrow duct to the spinning
warts is controlled by a valve located at the exit of the duct. As the
protein solution passes through the duct, the proteins are salted-
out and assemble, ﬁnally yielding silk ﬁbers with remarkable
mechanical properties.
The origin of the proteins’ solubility and anti-aggregation
behavior in the lumen of the glands has been the subject of some
debate; storage of the proteins in a liquid crystalline state was
a particularly attractive hypothesis that would explain the low
propensity to aggregation, the low viscosity of the solution, a low
critical shear rate for inducing crystallization, and the low draw
ratio necessary for the production of uniaxially aligned ﬁbrous
structures [168]. However, NMR studies carried out by Jelinski and
co-workers indicate that the proteins are stored in the lumen as
‘molten globules’. In solution, 13C chemical shifts of the alanines
indicate the presence of helices and random coils, and solid state
studies of the lyophilized protein show evidence of both 310-helices
and a-helices, suggesting that folding into the b-sheet conforma-
tion occurs during the spinning process [35].
In 2003, the Kaplan Group presented an alternative hypothesis
suggesting that the stability of B. mori silk proteins in the lumen of
the gland is due to the formation of micellar structures by the
amphiphilic proteins [169]. It was also suggested that the stability
of silk proteins in solution is due to the periodic hydrophobicity
inherent in their primary structure [170], as demonstrated in
theoretical models [171]. Our investigations using microﬂuidic
devices also support the latter model [172].
As the protein solution passes along the duct, a variety of
chemical and physical stimuli drive the assembly of the silk
proteins into ﬁbers [173]. For example, the protein solution is stored
in the lumen at pH 7.2, and as the protein solution passes along the
duct the pH drops to 6.3 encouraging aggregation of the proteins
(silk proteins tend to containmore acidic than basic residues, hence
their pI is typically in the region of 4–7) [174–176]. Ion exchange
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chloride ions present in the lumen are exchanged for the more
kosmotropic potassium and phosphate during passage along the
duct, encouraging protein self-assembly [170,177].
In addition to a decrease in pH and ion exchange, water is
extracted during ﬂow along the duct. Water extraction occurs via
a cuticle with the structure of a hollow ﬁber dialysis membrane that
lines the duct, concentrating the proteins inside the spinning dope,
and promoting aggregation [178,179].
Additionally, as the proteins ﬂow from the lumen along the
duct, they undergo shear-induced elongation and alignment,
encouraging hydrophobic and hydrogen bonding interactions. As
the ﬂow rate increases, so does the alignment of the proteins in
solution, resulting in more regular stacking of b-sheet-rich
regions, and therefore stiffer, stronger, but less extensible ﬁbers
[172,180–182].
Temperature has also been observed to affect the ﬁber forma-
tion process; experiments carried out by forcibly silking immobi-
lized live Nephila edulis spiders (non-anaesthetized) at a variety of
temperatures between 5 and 40 C show that as the temperature
increases, so does the breaking strain, and it was postulated that
the temperature dependence of the viscosity of the solution during
spinning was the cause of this effect [168,183].
We have used microﬂuidic devices in order to study the
assembly process of engineered spidroins (eADF-3 and eADF-4)
that are based upon the consensus sequences of one of the major
ampullate silks (ADF-3 and ADF-4) of A. diadematus spiders. We
demonstrated that ﬁber formation for eADF-3 requires a combina-
tion of salting out, pH drop and elongational ﬂow. Increasing the
phosphate concentration to 500 mM (salting out) induces the
assembly of eADF-3 into spherical aggregates. The pH drop (to pH
6) must be accompanied by elongational ﬂow to induce the
aggregation of the eADF-3 spheres into b-sheet-rich ﬁbers, i.e. ﬁber
formation does not occur in the absence of either a pH drop or
elongational ﬂow. In contrast, eADF-4 assembles into spheres under
all conditions tested, and only formed ﬁbers in the presence of
eADF-3 [172].2.3. Technical processing of silk proteins – ﬁbers
2.3.1. Non-naturally spun ﬁbers (mm scale diameters)
As described above, silkworms and spiders have both evolved
highly efﬁcient methods of spinning high performance silk ﬁbers
with mm scale diameters, and there have been a number of
attempts to mimic their processing techniques to enable the
production of ﬁbers from both natural and recombinant protein
sources. Fibers with mm scale diameters can be prepared by wet
spinning (extrusion of a solution of protein into a non-solvent/
coagulant), hand-drawing (literally drawing a ﬁber from solution
by hand) and microﬂuidic devices; some examples of the different
techniques and solvents used are highlighted below.ion 
exchange
silk
 thr
eaddope
phase separationprotein production thread assembly
extraction of water 
and shift of pH
highly concentrated 
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mechanical 
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opisthosoma of the spider exterior
Fig. 5. Biological processing of spider silk proteins – ﬁber spinning.2.3.1.1. Aqueous solvents. Fibers have been prepared via hand-
drawing from a 40 wt% solution of a 76 kDa engineered protein
(containing extensive repetitions of the hexapeptide GAGAGS
derived from the crystalline region of B. mori ﬁbroin) in 9 M LiBr
into an acetic acid–acetone coagulation bath. The ﬁbers were cured
in the coagulation bath under slight tension for 30 min, and
subsequently washed with water and air dried at 80 C. The
resulting ﬁbers had non-uniform diameter (10–20 mm) and poor
mechanical properties [184].
Fibers with diameters of ca. 9 mm were prepared by hand-
drawing from approximately 0.1 wt% aqueous solution of N. edulis
major ampullate spidroins (solutions were prepared by forcible
reeling of the silk from N. edulis spiders, dissolution of the ﬁbers in
8 M guanidinium hydrochloride, concentration by centrifugation,
and removal of the guanidinium hydrochloride by gel ﬁltration)
and b-sheet formation was induced by stretching the ﬁbers [185].
The extensibility of the resultant ﬁbers was similar to natural spider
silk, yet the other mechanical properties were poorer. Similarly,
ﬁbers with diameters of 7–21 mmwere hand-drawn from aqueous
solutions of engineered spidroins (containing repeat sequences
occurring in the ﬂagelliform (GPGGX) and major ampullate (A8)
proteins of N. clavipes) [112]. The extensibility of the ﬁbers was
comparable to native MaSpII spider silk, but the mechanical
strength was much lower. During our investigations of the ﬁber
spinning process, we also demonstrated the ability to prepare
b-sheet-rich ﬁbers (with diameters of ca. 5 mm) via hand-drawing
from concentrated aqueous solutions (>15% w/v) of eADF-3 [170].
In another approach, ﬁbers were prepared via wet spinning
20 wt% solutions of recombinant major ampullate spidroin 2 (from
N. clavipes) into a coagulant bath of either aqueous alcohol (meth-
anol or ethanol) or ammonium sulfate solution [186]. The ﬁbers
were drawn (improving their mechanical properties by alignment
of the b-sheet crystallites), washed with water and dried in air
(below 100 C). The resulting ﬁbers had uniform diameter of ca.
70 mm and mechanical properties sufﬁcient for certain tissue engi-
neering applications (although poorer than naturally spun spider
silks). In a similar approach, ﬁberswith diameters of 10–60 mmwere
wet-spun via extrusion of aqueous solutions of 25 wt% engineered
spidroins (43 or 55 kDa proteins containing consensus sequences
from major ampullate spidroins 1 and 2 from N. clavipes) into an
aqueous-methanol coagulation bath. As expected, drawing of the
ﬁbers aligned the b-sheet crystallites, however, the poormechanical
properties of the ﬁbers and a lack of pure material prevented
acquisition of mechanical data on these proteins [187]. This spin-
ning process was further improved by post-spin double drawing,
yielding ﬁbers with diameters of 10–40 mm [188] with mechanical
properties similar those reported for wet-spun regenerated spider
silk [189], yet still poorer than naturally spun spider silks.
We have demonstrated that it is possible to prepare ﬁbers from
aqueous solutions of eADF-3 (and blends with eADF-4) at
a concentration of 20 mg/ml using a microﬂuidic device. A combi-
nation of salting out, pH drop and elongational ﬂow within the
microﬂuidic device yields b-sheet-rich ﬁbers with diameters of ca.
1–5 mm.Mechanical tests of ﬁbers produced in this fashion could be
performed with atomic force microscopy or optical tweezers,
enabling detailed investigation of structure–function relationships
of the proteins [172].
2.3.1.2. Non-aqueous solvents. Silk proteins have been shown to be
soluble in certain non-aqueous solvents, and there have been
a number of reports of ﬁber spinning from non-aqueous solvents.
The ﬁrst of these described the wet spinning of ﬁbers from 5 to
25 wt% solutions of B. mori ﬁbroin in hexaﬂuoroisopropanol (HFIP)
into a methanol coagulation bath. Naturally spun B. mori ﬁbroin
ﬁbers are insoluble in HFIP, hence HFIP solutions were prepared by
dissolving degummed B. mori ﬁbroin in 12.5 M lithium thiocyanate,
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aqueous solution of denatured ﬁbroin. The solvent was allowed to
evaporate, yielding a ﬁlm of ﬁbroin that was found to be HFIP
soluble [190].
The wet-spun ﬁbers were left in the bath overnight to allow
diffusion of the HFIP from the ﬁber, then hand-drawn to the desired
draw ratio whilst still wet with methanol, and ﬁnally immobilized
to prevent recoil before drying overnight. The treatment with
methanol induced b-sheet formation, rendering the ﬁbers insoluble
in HFIP. Their mechanical strength (initial moduli and tenacity)
exceeded that of natural silkworm ﬁbers. Investigation of this wet-
spinning process in greater detail showed that B. mori ﬁbroin
adopts a predominantly a-helical structure in HFIP solution, and
extrusion of this solution into methanol produced b-sheet-rich
ﬁbers with diameter of ca. 160 mm. The b-sheet crystallites in
undrawn ﬁbers are randomly oriented, and post-spin drawing
reduced the diameter of the ﬁbers to ca. 90 mm, increased the
b-sheet content of the ﬁber and aligned these crystallites with the
axis of the ﬁber [191]. In order to improve this technique, a wet-
spinning apparatus was designed for the preparation of ﬁbers (with
diameters from 10 to 100 mm) from small quantities (ca.10 mg) of B.
mori ﬁbroin, which would be useful for recombinant proteins
produced in small quantities [192].
Naturally spunmajor ampullate silk from N. clavipes is soluble to
a certain extent in HFIP, and initial attempts to wet-spin 2.5 wt%
solutions of N. clavipes spidroin in HFIP into an acetone coagulation
bath resulted in ﬁbers with diameters of ca. 40 mm containing
surprisingly high levels of residual HFIP even after storage under
vacuumat 60 C. Solvation of the ﬁber by residualHFIP is reﬂected in
the high a-helix content and low b-sheet content relative to that in
naturally spun silk ﬁbers and explains the poor mechanical proper-
tiesof theseﬁbers. Soaking theﬁbers inwater removedresidualHFIP,
and encouraged further b-sheet formation, although the ﬁbers still
had poormechanical properties [193]. This processwas signiﬁcantly
improved by drawing the ﬁbers whilst they were wet with acetone,
soaking in water, and a second drawing whilst wet with water. The
mechanical properties of the resultant ﬁbers (with diameters of ca.
30 mm) were comparable to (yet poorer than) naturally spun spider
silks (strength 320 MPa vs. 875 MPa in naturally spun silk; and
modulus 8.0 GPa vs. 10.9 GPa in naturally spun silk) [189].
HFIP is not the only organic solvent that has been used to process
silk proteins, especially since certain silk proteins are insoluble or
poorly soluble in HFIP as described above. Hexaﬂuoroacetone
hydrate (HFA-hydrate)was demonstrated to be a superior solvent to
HFIP as it can dissolve naturally spun B. mori and Samia cynthia ricini
ﬁbroin ﬁbers (which are insoluble inHFIP). Itwas also demonstrated
that it was possible to prepare ﬁbers by wet-spinning 10 wt% solu-
tions of B. mori ﬁbroin in HFA-hydrate into a methanol coagulation
bath (although this process did notwork for S. cynthia ricini ﬁbroin).
Washing and drawing in water and subsequent steam annealing
yielded ﬁbers with aligned b-sheet crystallites [194].
Ionic liquids such as 1-ethyl-3-methylimidazolium chloride and
1-butyl-3-methylimidazolium chloride have been demonstrated to
be good solvents for naturally spun B. mori ﬁbroin ﬁbers, producing
b-sheet free solutions [195]. It was also demonstrated that it was
possible to prepare ﬁbers bywet-spinning 10 wt% solutions of B. mori
ﬁbroin in 1-ethyl-3-methylimidazolium chloride into a methanol
coagulation bath inducing b-sheet formation. The ﬁbers were left in
the coagulation bath overnight to remove the residual 1-ethyl-3-
methylimidazolium chloride, yielding clear solid ﬁbers of 250 mm
diameter. Post-spindrawingof theﬁbers to twice their length reduced
their diameters to 150 mm, and aligned the b-sheet crystallites.
Unfortunately, in both cases the ﬁbers were brittle when dried [196].
In contrast to halogenated [197–200] or ionic liquid solvents
[201–206], N-methyl morpholine N-oxide (NMMO) is a cheap
environmentally friendly organic solvent. Fibers have beenprepared by wet-spinning 10–25 wt% solutions of B. mori ﬁbroin in
NMMO monohydrate into methanol or ethanol coagulation baths,
collected by reeling, washed in either methanol or water, drawn
whilst still wet and left to dry in air. The diameter of the ﬁnest ﬁbers
was 19 mm, yet the mechanical properties of these ﬁbers were
poorer than naturally spun ﬁbers [207–210].
2.3.2. Electrospun ﬁbers (nm scale diameters)
Electrospinning is a popular technique for the preparation of
ﬁbers with nanoscale diameters. The typical experimental setup
involves pumping a solution of polymer through a needle, forming
a droplet at the tip. Application of a voltage to the tip causes the
droplet to stretch into a structure known as a Taylor cone. If the
solution viscosity is too low, droplets are electrosprayed, whereas if
the solution is sufﬁciently viscous an electriﬁed jet is formed. The
jet is elongated and stretched by electrostatic repulsion resulting in
the preparation of ﬁbers with uniform nanometer scale diameters.
2.3.2.1. Aqueous solvents. Early attempts to electrospin B. mori
ﬁbroin from relatively dilute aqueous solutions were unsuccessful
due to the surface tension and viscosity of the solution being too
low to maintain a stable drop at the end of the needle tip. The
addition of up to 1.8 wt% PEO to 2–7 wt% B. mori ﬁbroin solutions
altered the surface tension and viscosity of the solution enough to
allow smooth ﬁbers with diameters of 590–910 nm to be success-
fully electrospun from aqueous solutions [211,212]. Treatment of
these ﬁbers with 90/10 (v/v) methanol/water induced a conforma-
tional change from random coil to predominantly b-sheet, and the
surface of the ﬁbers became rough due to phase separation of
ﬁbroin and PEO, and potentially extraction of some of the PEO. It
was later found that using more concentrated solutions of B. mori
ﬁbroin (ca. 28 wt%) increased the surface tension and viscosity of
the stock solution enough to enable the successful electrospinning
of ﬁbers with an average diameter of 700 nm and some b-sheet
content [213,214]. It is also possible to electrospin ﬁbers with
a core/shell morphology by a two-ﬂuid electrospinning technique
and water as the common solvent [215]. The two-ﬂuid electro-
spinning process (one ﬂuid containing B. mori ﬁbroin and the other
PEO) is the key to produce a core ﬁlament of unblended ﬁbroin and
allowed a variety of core/shell diameters to be prepared.
2.3.2.2. Non-aqueous solvents. Fibers can also be electrospun from
solutions of silk proteins in suitable non-aqueous solvents. It has
been demonstrated that it is possible to electrospin ﬁbers from
solutions of 0.2–1.5 wt% B. mori ﬁbroin and N. clavipes major
ampullate silk in HFIP. The ﬁbers had diameters that were tunable
between 2 and 2000 nm. The as-electrospun ﬁbers were a-helix-
rich, and b-sheet formation was induced by high temperature
annealing (205–245 C for B. mori ﬁbroin or 210–225 C for N.
clavipes major ampullate silk) [216]. It has also been demonstrated
that it is possible to electrospin ﬁbers from HFA-hydrate solutions
of both B. mori ﬁbroin (3 wt%) and S. cynthia ricini ﬁbroin (10 wt%)
(previous attempts to wet-spin S. cynthia ricini ﬁbroin were
unsuccessful). Soaking the ﬁbers in methanol overnight, followed
by storage under vacuum for two days removed the residual HFA-
hydrate from the ﬁbers. The ﬁbers were b-sheet-rich and had
diameters tunable between 100 and 1000 nm. Interestingly, in the
case of the S. cynthia ricini ﬁbroin ﬁbers, the as-spun ﬁbers were
b-sheet-rich, and post-spin treatment with methanol only served
to remove the residual HFA-hydrate from the ﬁbers [217].
2.4. Technical processing of silk proteins – other morphologies
In addition to ﬁbers, silk proteins can be processed into a diverse
set of morphologies, and the following section of the review is
devoted to their preparation.
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Fig. 6. Top: an AFM deﬂection image of air dried self-assembled silk nanoﬁbrils and
bottom: an SEM image of a hydrogel prepared from recombinant spider silk protein.
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Gels are solid-like materials, comprising a liquid that is immo-
bilized by another component, where the other component is more
commonly known as the gelator. Gel phase materials have a variety
of applications including cosmetics and drug delivery.
2.4.1.1. Aqueous solvents. Spontaneous hydrogelation occurs in
a matter of hours in sufﬁciently concentrated aqueous solutions of
B. mori ﬁbroin (>23 wt%) due to inter- and intramolecular inter-
actions of the proteins in solution. Inter- and intramolecular
b-sheet formation lowers the solubility of ﬁbroin in water,
encouraging the formation of physical cross-links between the
proteins that eventually leads to hydrogelation. Hydrogelation at
lower ﬁbroin concentrations also occurs, although the timescale of
this process is highly concentration-dependent (at concentrations
below 4 wt% this process takes many days under comparable
conditions). A pH near the isoelectric point of ﬁbroin (pI¼ 3.8–3.9)
[218,219] accelerates gelation, as the proteins are more prone
to aggregation due to hydrophobic interactions. The presence of Kþ
ions was found to have no effect upon the kinetics of gelation
between 2.5 and 20 mM, whereas the presence of Ca2þ ions in
the same concentration range is found to decrease the gelation
time.
SEM images of freeze-dried gels show that in the presence of Kþ
ions the ﬁbroin had a ﬂat ‘leaf-like’ morphology; by comparison,
the presence of Ca2þ ions causes the ﬁbroin to self-assemble into
highly cross-linked sponge-like morphologies potentially due to
Ca2þ mediated inter- and intramolecular interactions. Gelation
time is also dramatically reduced (from days to hours) as the
temperature increased from room temperature to 60 C. There are
two explanations for this, ﬁrstly, that hydrophobic regions of
proteins are less well solvated at higher temperatures, encouraging
aggregation through hydrophobic interactions; and secondly, that
proteins unfold at higher temperatures, exposing more hydro-
phobic regions to water thereby encouraging aggregation
[220,221]. Gelation time could also be reduced to a matter of hours
by ultrasonication, as this dehydrates the hydrophobic segments,
hence promoting aggregation [222]. Similarly, engineered ﬁbroins
based upon the consensus sequences of B. mori ﬁbroin have been
demonstrated to form hydrogels with various biomedical applica-
tions [223–231].
Hydrogel formation is also possible with spider silk proteins.
The major ampullate silk proteins (of A. diadematus spiders) are
stored in the lumen at approximately pH 7.4 without the onset of
undesirable aggregation. Lowering the pH to 5.5 (protonation of
carboxylate anions) was observed to trigger gelation, as the
proteins were more prone to aggregation due to hydrophobic
interactions. Interestingly, returning the pH to 7 (deprotonation of
the carboxylates) reverses the assembly process [174].
We have demonstrated that certain engineered spidroins
(eADF-4 proteins) spontaneously form hydrogels (at concentrations
of ca. 2 wt%) composed of nanoﬁbrillar assemblies [232–234]. The
self-assembled hydrogels could be disrupted by agitation or
shearing, and chemical cross-linking of the hydrogels (10 mg/ml
protein) with ammonium peroxodisulfate and tris(2,20-bipyr-
idyl)dichlororuthenium(II) (a light-inducible cross-linker) yielded
elastic hydrogels [233] (Fig. 6).
2.4.2. Foams
Foams can be prepared by a variety of techniques allowing ﬁne
control of their three-dimensional structure and mechanical
properties, which ultimately dictates what they may be used for.
2.4.2.1. Aqueous solvents. Foams can be formed by bubbling gases
through aqueous solutions of B. mori ﬁbroin due to its surfactant-
like properties [235], and foams prepared from slightly acidicsolutions were observed to be b-sheet-rich [236–242]. Foams can
also be prepared via freeze-drying hydrogels formed with B. mori
ﬁbroin [243]. Early studies demonstrated that the pore structure of
the foams could be controlled via freezing temperature, solution pH
or the addition of methanol.
Kaplan and co-workers reported the preparation of mechani-
cally stable foams via freeze-drying B. mori ﬁbroin hydrogels with
pore sizes in the region of 10–70 mM, porosity up to 99% and
a maximum compressibility of 30 kPa [244]. They also prepared
mechanically stable B. mori ﬁbroin foams by casting an aqueous
solution of ﬁbroin onto a salt template, and subsequently washing
away the salt (a process commonly known as salt-leaching). This
procedure generated foams with pore sizes between 470 and
940 mM, porosities of>90%, and compressive strength between 300
and 3800 kPa depending upon the processing conditions [245].
2.4.2.2. Non-aqueous solvents. Mechanically stable B. mori ﬁbroin
foams can additionally be prepared by pouring a solution of ﬁbroin
in HFIP over ammonium bicarbonate granules. Evaporation of HFIP
followed by treatment with methanol induces b-sheet formation,
and ﬁnally treatment with hot water causes sublimation of the
ammonium bicarbonate template and expansion of the foam. This
process yields foams with pore sizes between 40 and 260 mM,
porosity up to 97% and a maximum compressibility of 280 kPa
[244]. Alternatively, following a similar procedure using a sodium
chloride template yielded foams with pore sizes between 100 and
300 mM, porosities of 84–98%, and compressive strength up to
175 kPa [244]. An adaptation of this process allowed the prepara-
tion of foams with a gradient of pore sizes (by packing differently
sized salt particles into containers) resulting in foams with struc-
tures analogous to bone [246].
2.4.3. Films
Films are generally prepared by casting solutions of silk proteins
onto a substrate and allowing the evaporation of the solvent. Once
the solvent has evaporated, the ﬁlms can be peeled off for further
use, modiﬁed chemically (e.g. cross-linked), or modiﬁed structur-
ally via treatment with another solvent.
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tions of B. mori ﬁbroin are mechanically weak, and typically
unstructured or a-helix-rich. b-sheet formation can be induced by
treatment with methanol [247–249], annealing at high tempera-
ture [247], stretching [250], storage [251], or UV radiation [251].
Such conformational conversion renders the ﬁlms insoluble in
water and improves their mechanical properties. Interestingly,
exposure to g-radiation (from a Co57 g-ray source) induces
decrystallization of the b-sheets [250,252]. Mechanically stable
ﬁlms may be prepared by casting ﬁlms from aqueous solutions of B.
mori ﬁbroin with a suitable cross-linking agent (such as poly-
ethylene glycol diglycidyl ether) and drying at 40 C for 4 h [253].
It is possible to prepare porous ﬁlms by casting aqueous solutions
of B. mori ﬁbroin and a suitable porogen such as polyethylene oxide.
Treatment of the ﬁlms with aqueous methanol induces b-sheet
formation, and the polyethylene oxide could subsequently be
washed away with water yielding porous ﬁlms. The topography of
theﬁlms is tunablevia the ratioofﬁbroin topolyethyleneoxide [254].
2.4.3.2. Non-aqueous solvents. As with the preparation of ﬁbers,
gels and foams, ﬁlms can also be made from solutions of silk
proteins in non-aqueous solvents. Films have been formed via
casting or dip-coating solutions of engineered B. mori ﬁbroins in
formic acid [255,256]. Scanning probe microscopy carried out on
these ﬁlms allowed the investigation of periodic features and the
length-scale dependence of the surface roughness, which deter-
mine if cells can adhere to the ﬁlms, and is therefore important for
biomedical implants.
It has also been demonstrated that it is possible to prepare ﬁlms
by casting ca. 10 wt% solutions of B. mori ﬁbroin in 1-butyl-
3-methylimidazolium chloride onto a substrate. The 1-butyl-
3-methylimidazolium chloride was washed away with methanol
(inducing b-sheet formation) yielding clear solid ﬁlms with a rough
surface [195]. Films prepared via a similar procedure using
a patterned template as a substrate, followed by removal of the
template, gave patterned B. mori ﬁbroin silk ﬁlms that were suitable
for use as scaffolds to support cell proliferation and growth [257].
We have cast a-helix-rich ﬁlms from solutions of recombinant
spidroins in HFIP and b-sheet formation was induced by exposure
of the ﬁlms to methanol or potassium phosphate rendering the
ﬁlms insoluble in water. We have also cast b-sheet-rich ﬁlms from
solutions of recombinant spidroins in formic acid. The surface of
such ﬁlms could be chemically modiﬁed via carbodiimide-medi-
ated coupling of active enzymes through the carboxylic acid groups
displayed on the backbone of the spidroin [258–261].
2.4.4. Spheres and capsules
Due to their highly tunable structures, spheres and capsules are
very popular morphologies in applications such as the encapsula-
tion and delivery of active ingredients including drugs, dyes, ﬂavors
or perfumes.
2.4.4.1. Aqueous solvents. As described above, spontaneous hydro-
gelation occurs in a matter of hours in sufﬁciently concentrated
aqueous solutions of B. mori ﬁbroin (>23 wt%), whereas at
concentrations below 4 wt% this process takes many days under
comparable conditions. SEM images of freeze-dried 2 wt% solutions
of B. mori ﬁbroin show smooth sponge-like morphologies. The
addition of methanol (10% v/v) to these solutions induced b-sheet
formation and made the morphology of the sponges rough; high
magniﬁcation images of the sponges revealed that they were
composed of aggregated particles. It was demonstrated that the
particles formed when using ﬁbroin with a molecular weight
between 40 and 100 kDa were large and irregularly shaped,
whereas use of ﬁbroin with a molecular weight between 20 and
40 kDa resulted in smooth spheres of ca. 1 mm [262].Microspheres may also be prepared via spray drying aqueous
solutions of B. mori ﬁbroin followed by storage in a desiccator to
assure that the particles were dry [263]. The as-sprayed micro-
spheres were unstructured with diameters of approximately 5 mm.
The particles could be stored for up to a month with no change in
the secondary structure of the ﬁbroin, whereas storage at a relative
humidity of 89% for 24 h allowed crystallization [264,265] of the
b-sheet forming segments of the protein, rendering the micro-
spheres insoluble in water.
Lipids such as 1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC)
self-assemble into uni- andmultilamellar vesicles that may be used
for drug delivery [266–271]. Large multilamellar vesicles are
commonly transformed into small unilamellar vesicles simply via
freezing and thawing solutions of multilamellar vesicles [272,273].
Kaplan and co-workers have used largemultilamellar DOPC vesicles
for the encapsulation of B. mori ﬁbroin and protein drugs, and
subsequently generated small unilamellar vesicles by freezing and
thawing steps, lyophilization of which yielded a free-ﬂowing
powder. Treatment of the powder with either methanol or aqueous
sodium chloride induced b-sheet formation in the ﬁbroin (entrap-
ping the protein drugs) and removed the DOPC, yielding water-
insolublemicrospheres (ca. 2 mm)with amixture of unilamellar and
multilamellar structures [274].
We have prepared microspheres using one of the aforemen-
tioned engineered spidroins eADF-4 (see Fig. 7). The addition of
potassium phosphate at concentrations >400 mM to solutions of
eADF-4 spidroin leads to the formation of smooth solid b-sheet-rich
microspheres, through the liquid–liquid phase separation of
a protein-rich phase in a protein-poor supernatant due to the salting
out of the protein-rich phase. Sphere size can be controlledwith two
simple parameters, protein concentration and mixing intensity;
increasing the protein concentration resulted in larger micro-
spheres,whereas increasing themixing intensity resulted in smaller
microspheres [275,276].
We have also demonstrated that eADF-4 spidroin spontaneously
assembles at a toluene/water interface in water-in-toluene emul-
sions. This assembly process results in b-sheet-rich capsules that
are mechanically and chemically stable (see Fig. 7). The microcap-
sules can be transferred into aqueous solution either via centrifu-
gation into an aqueous sub-layer, or dilution of the toluene by the
addition of an excess of ethanol and water. Adjusting the emulsion
droplet diameter allows tuning of the microcapsule diameter
between 1 and 30 mm [277,278].
3. From science towards applications
3.1. Textiles
B. mori silk ﬁbers have been used for the production of textile
goods for centuries due to their characteristic luster, moisture
absorbance and strength. Early research was largely focused on
dyeing methodology and dealing with its shortcomings (photo-
yellowing [279–281], rub resistance [282] and wrinkle recovery
[283]).
Attractively colored B. mori silk ﬁbers can be prepared by various
dyeing processes, and ﬁber dyeing has been achieved with acidic
[284–287], basic [288], azo [289], disperse [290–294], mordant
[295,296], natural [297,298] and reactive dyes [299,300]. There is
a vast quantity of literature detailing dye synthesis and ﬁber dyeing
processes due to their economic importance.
The variety of reactive amino acid residues displayed on the
backbone of silk proteins has provided synthetic chemists with
plenty of scope for the modiﬁcation of their properties. Modiﬁca-
tion of B. mori ﬁbroin ﬁbers with various acid anhydrides improved
their crease recovery properties and protected them from photo-
yellowing [279,282,301–303], primarily due to chemical
Fig. 7. SEM and optical microscope images of microspheres and microcapsules of eADF-4.
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dibasic acid anhydrides markedly improved the cationic dye
afﬁnity [304].
Another method of modifying the properties of silk proteins is
the preparation of graft copolymers (imparting some of the
properties of the grafted polymer). Fibroin-graft-(methyl methac-
rylate) [305] and ﬁbroin-graft-vinyltrimethoxysilane [306] showed
improved wrinkle recovery; ﬁbroin-graft-(hydroxy-ethyl methacry-
late)-co-(methacrylamide) [307] displayed an increased moisture
content; and ﬁbroin-graft-styrene [308,309] showed higher afﬁnity
for disperse dyes and can consequently be applied in heat transfer
printing.
Water-repellent silk ﬁbers have been prepared via reaction of B.
mori ﬁbroin ﬁbers with alkyl acid anhydrides [310,311], or coating
naturally spun major ampullate silk ﬁbers produced by N. edulis
spiders with hydrophobic gold nanoparticles [312], at no detriment
to their mechanical properties.
We envisage that, in the future, biotechnologically produced silk
ﬁbers will allow the preparation of a new generation of high
performance ﬁbers with even more built-in properties for a variety
of textiles related applications.
3.2. Sutures for wounds
Silk ﬁbers have been used as sutures for wounds for centuries
due to their strength, biocompatibility and low immunogenicity,
yet only recently have detailed biological studies been undertaken
[313–315]. The mechanical properties of sutures determine if they
are successful in their application, therefore the investigation of the
properties of ﬁbers and yarns is of great importance [316]. Braided
yarns could be used as stiff sutures for wounds where small
diameter yarns are preferable, and tissue in-growth is unnecessary
[317,318].
3.3. Tissue scaffolds
Tissue engineering is the development of substitutes for bio-
logical tissues that replace or restore tissue function. Tissue scaf-
folds are the extracellular matrices designed to support the cellsthat constitute the tissue to be replaced or restored. Silk-based
polymeric materials are interesting tissue scaffolds due to their
biocompatibility and their highly tunable morphologies.
Silk ﬁbers that have been spun into yarns and subsequently
textured via permanent deformation may be useful as non-load-
bearing spacers in tissue grafts where tissue in-growth is desirable.
Cabled yarns have highly tunable mechanical properties and
therefore potential in load-bearing tissue engineering applications
[317].
Fibers electrospun from aqueous solutions of B. mori ﬁbroin and
PEO were used as a scaffold for human aortic endothelial cells
(HAECs) and human coronary artery smooth muscle cells
(HCASMCs); in both cases in vitro culture in endothelial growth
medium led to the formation of vascular tissueswithin aweek [211].
Stem cells can differentiate into a diverse range of specialized
cell types and their use in implanted tissue scaffolds has been
proposed [319]. Human mesenchymal stem cells (hMSCs) can be
isolated from bone marrow aspirates, and can form bone, cartilage,
fat and other connective tissues, and therefore have signiﬁcant
potential in the regeneration of diseased or injured tissues. Fibers
electrospun from aqueous solutions of B. mori ﬁbroin, PEO and bone
morphogenetic protein-2 (BMP-2) were used as a scaffold for
hMSCs; in vitro culture in osteogenic media led to the formation of
bone-like tissue. Addition of hydroxyapatite nanoparticles to the
ﬁbroin solution prior to electrospinning produced ﬁbers with the
nanoparticles embedded inside and was found to improve bone
formation [320]. In vivo implantation of electrospun B. mori ﬁbroin
ﬁbers in calvarial defects in mice facilitated the complete healing of
the defect with new bone within 12 weeks [321].
Manually silked major ampullate silk ﬁbers (from adult female
spiders of the genus Nephila) have been used as a scaffold for nerve
cell growth in vitro. Schwann cells were observed to adhere quickly,
and proliferate and survive successfully, and the cells completely
ensheathed the ﬁbers within a week of cultivation [322]. Recent in
vivo studies in rats have demonstrated successful nerve regenera-
tion with regrowth of regularly aligned axons [323].
B. mori ﬁbroin hydrogels have been used as a scaffold for hMSC
growth in vitro. The cells were able to grow, proliferate and survive
for weeks in static culture conditions [222]. Similarly, B. mori ﬁbroin
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both in vitro and in vivo in rabbits without inﬂammatory effects
[324–326].
As a further alternative silk morphology, foams prepared from B.
mori ﬁbroin have been used as scaffolds for the attachment and
proliferation of ﬁbroblasts in vitro. It was observed that cell colonies
were located preferentially at the surface of the foam, potentially
due to the cell-seeding process, and/or lack of nutrients inside the
foam [327]. Foams seeded with hMSCs in chondrogenic medium
formed cartilage-like tissue, whereas those in osteogenic medium
formed bone-like tissue [246,328]. Importantly, foams seeded
with adipose derived stem cells formed adipose-like tissue in vivo
in rats [329].
It has proven possible to prepare artiﬁcial blood vessels by
coating steel wires with porous ﬁlms of B. mori ﬁbroin, and
subsequently removing the wire template. Porous ﬁlms were
prepared by casting aqueous solutions of B. mori ﬁbroin and PEO (a
ﬁbroin immiscible porogen). Treatment of the ﬁlms with aqueous
methanol induces b-sheet formation and the polyethylene oxide
could subsequently be washed away with water yielding porous
ﬁlms [254]. The level of porosity was controlled by varying the ratio
of ﬁbroin to PEO, and the diameter of the ﬁbroin-based vessels was
determined by that of the wire template. Low porosity microtubes
demonstrated superior mechanical properties in terms of higher
burst pressures, but displayed poor protein and cell permeability;
whereas higher porosity tubes had lower burst strengths but
increased permeability and enhanced protein and cell permeability
[330].
3.4. Biocompatible coatings
Coatings are commonly applied to the surface of materials to
improve their surface properties. The biocompatibility and non-
immunogenicity of silk proteins should allow their application as
coatings for biomedical implants, potentially as anticoagulants, and
either promoters or inhibitors of cell adhesion.
Water soluble anticoagulants (such as the highly sulfated poly-
saccharide heparin) are commonly used for blood treatment during
dialysis and surgery, and water-insoluble anticoagulants are useful
coatings for implants such as stents. Sulfation of water soluble B.
mori ﬁbroin (modifying the amine and hydroxyl containing resi-
dues) was found to impart anticoagulant activity to the ﬁbroin
[331–333], and more recently B. mori silk fabrics were sulfated for
application as water-insoluble anticoagulants [334,335].
B. mori ﬁbroin ﬁlms cast from aqueous or HFIP solution and
subsequently treated with methanol (inducing b-sheet formation)
are suitable for osteoblast-like cell adhesion, and it has been
demonstrated that cell adhesion can be signiﬁcantly improved
using ﬁlms cast from ﬁbroin that has been chemically modiﬁed
with the RGD integrin recognition sequence that is well-known for
its cell-adhesive properties [336]. Peptides derived from the
repetitive motif found in collagen [GERGDLGPQGIAGQRGVV-
(GER)3GAS]8GPPGPCCGGG and ﬁbronectin [TGRGDSPAS]8 were
demonstrated to be cell-adhesion sites in in vitro studies. Geneti-
cally engineered chimeric proteins based upon B. mori ﬁbroin and
the peptides above should be capable of both self-assembly and
cell-adhesion. Films cast from solutions of these genetically engi-
neered chimeric proteins were demonstrated to have much
improved cell-adhesion properties over those cast from B. mori
ﬁbroin alone; additionally, the cost of these materials would be
a fraction of the cost of collagen or ﬁbronectin [337].
Many sugar residues in lipids and proteins are involved in the
recognition of lectins present on cell surfaces. Films cast from
aqueous solutions of B. mori ﬁbroin chemically modiﬁed with
a sugar (lactose bearing the b-galactose residue) were treated with
aqueous methanol solution to induce b-sheet formation, andrender the ﬁlms insoluble in water. Levels of hepatocyte attach-
ment to the ﬁlms cast from lactose conjugated ﬁbroin was
demonstrated to be ca. eight times higher than ﬁlms cast from
unmodiﬁed ﬁbroin [338].
2-Methacryloyloxyethyl phosphorylcholine (MPC) inhibits
blood cell–platelet, monocyte and macrophage adhesion. The graft
polymerization of MPC onto B. mori silk fabrics yielded fabrics with
the desirable mechanical strength of silk fabrics that signiﬁcantly
inhibit blood cell–platelet adhesion to ca. 10% of the level of the
untreated fabric, that are expected to have potential as sutures or
wound dressings [339,340].
3.5. Biomineralization
The process by which biological organisms produce mineralized
tissues such as bones, diatoms, shells and teeth is known as bio-
mineralization. The biomimetic use of biomineralization processes
to construct organic–inorganic hybridmaterials is a very active area
of research. Silk-based materials have been used as organic scaf-
folds for the biomineralization of hydroxyapatite (found in bones
and teeth) and silica (found in diatoms).
Naturally spun major ampullate silk ﬁbers (from daddy longlegs
spiders) have been used as a template for the nucleation and
growth of oriented hydroxyapatite crystals [341].
B. mori ﬁbroin ﬁlms with calcium chloride contents of 5 wt% or
greater were prepared by casting from aqueous solution, and
b-sheet formation was induced by treatment with methanol.
Incubation of the ﬁlms in simulated body ﬂuid led to the growth of
hydroxyapatite crystals in a matter of hours [342,343].
Naturally, dentin matrix protein 1 is involved in the nucleation
and oriented crystallization of hydroxyapatite. Genetically engi-
neered chimeric proteins based upon major ampullate spidroin
(from N. clavipes) and dentin matrix protein 1 are capable of both
self-assembly and biomineralization. Films cast from HFIP solution
were treated with methanol to induce b-sheet formation in the
major ampullate domain of the chimeric protein, rendering the ﬁlm
insoluble in water. Incubation of the ﬁlms in simulated body ﬂuid
led to the growth of hydroxyapatite crystals on the surface of the
ﬁlm, whereas ﬁlms cast from the control proteinwithout the dentin
matrix protein 1 domain did not induce biomineralization [344].
Silafﬁns are low molecular weight proteins involved in silica
formation in nature. In vitro studies using a peptide derived from
the repetitive motif found in silafﬁn proteins (known as the R5
peptide) demonstrated that this peptide promotes and regulates
silica formation at neutral pH. Genetically engineered chimeric
proteins based upon major ampullate spidroin (from N. clavipes)
and R5 peptide are capable of both self-assembly and bio-
mineralization. Fibers electrospun from HFIP solution, and ﬁlms
cast from HFIP solution were treated with methanol to induce
b-sheet formation in the major ampullate domain of the chimeric
protein, rendering the materials insoluble in water. Incubation of
the ﬁbers and ﬁlms with a water soluble silicon species led to
biomineralization [345].
3.6. Drug delivery
For a drug to have its optimal effect it is important that its
release proﬁle is both reliable and controlled, particularly impor-
tant in cases where the drugs have undesirable side effects. Silk
proteins may ﬁnd application in drug delivery as drug carriers
owing to their biocompatibility and their highly tunable
morphologies.
L-Asparaginase has been used in clinical trials in humans to
prevent the progress of L-asparagine-dependent tumors, however,
its half-life of activity is limited due to rapid clearance, and it is both
antigenic and immunogenic. Conjugation of L-asparaginase to
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life and reduces its antigenicity and immunogenicity in vitro [346].
Hydrogels formed from B. mori ﬁbroin were demonstrated to
control the release of model drugs with molecular weights ranging
from ca. 350 Da to 4.5 kDa, and of buprenorphine (a morphine-like
drug used in the treatment of acute pain) in vitro. Tuning of the gels’
mechanical properties and rate of drug releasewas achieved simply
by varying the concentration of ﬁbroin [347]. Hydrogels formed
from engineered proteins based upon B. mori ﬁbroin were demon-
strated to similarly control the release of model drugs with mole-
cular weights ranging from ca. 400 Da to 500 kDa, and of Pantarin (a
mitotoxic protein) in vivo in guinea pigs, with no clinical signs of
tissue reactiondue to allergy, irritancyor toxicity after 28days [348].
Foams prepared via freeze-drying aqueous solutions of B. mori
ﬁbroin and aspirin were demonstrated to be capable of controlled
release of the aspirin trapped in the scaffold. Preliminary in vitro
kinetic studies showed a burst release proﬁle for the aspirin, with
a signiﬁcant quantity of aspirin released in the ﬁrst 2 h, followed by
an almost constant rate of release thereafter [243].
Films of B. mori ﬁbroin and carbodiimide cross-linked B. mori
ﬁbroin were deposited on tablets of theophylline (a drug used in
therapy for respiratory diseases such as asthma) via dip-coating.
The carbodiimide cross-linked ﬁlmsweremoremechanically stable
and allowed controlled release to be achieved for signiﬁcantly
longer periods of time with zero order release kinetics in vitro;
moreover, multiple coatings allowed the ﬁne tuning of the rate
constants [349,350]. Films of B. mori ﬁbroin and various macro-
molecular drug models (FITC-labelled dextrans, horseradish
peroxidase and lysozyme) were shown to be capable of controlled
release of the macromolecular model. b-Sheet-rich ﬁlms showed
a stronglymolecular weight dependent retardation of the release of
all of the macromolecular drug models in vitro [351]. Multilayered
B. mori ﬁbroin ﬁlms have been used as drug-eluting coatings for
stents, incorporating clopidogrel, heparin, and paclitaxel. Clopi-
dogrel and paclitaxel were observed to retard human aortic
endothelial cell (HAEC) proliferation and inhibit human coronary
artery smooth muscle cell (HCASMC) proliferation. Heparin loaded
silk ﬁlms inhibited HCASMC proliferation and promoted HAEC
proliferation, which is ideal for the prevention of restenosis.
Moreover, preliminary studies show that these ﬁlms are also
functional in vivo in porcine aorta [352].
Alginate and PLGA microspheres containing model enzyme
drugs were coated with a B. mori ﬁbroin ﬁlm. The as-cast ﬁlmsTOLUENEWATER
WATER WATER
capsules
spheres
Fig. 8. Schematic of microcapsule and microsphere formation. Top: an aqueous solution of e
of the protein at the toluene/water interface, yielding microcapsules (containing the drug) th
of eADF-4 (red) and drug (green) is exposed to high concentrations of potassium phospha
supernatant (due to the salting out of the protein-rich phase), yielding drug containing miretarded the rate of release of the drugs when compared to
uncoated controls in vitro, and could be further retarded by
induction of b-sheet formation by treatment of the ﬁlms with
methanol [353]. B. mori ﬁbroin microspheres prepared using lipid
vesicle templates have been used for the efﬁcient encapsulation
and controlled release of an active model protein drug (horseradish
peroxidase) in vitro [274].
We have demonstrated that microspheres prepared using one of
our engineered spidroins (eADF-4) are capable of the encapsulation
of poorly water soluble substances such as b-carotene, and that
these microspheres were undigested in artiﬁcial gastric ﬂuid and
completely digested in artiﬁcial intestinal ﬂuid at 37 C. This sort of
controlled release gives them potential use as delivery vehicles for
hydrophobic compounds (such as drugs or food ingredients) that
remain intact in the stomach and release the compounds in the
small intestine [354].
We have also prepared b-sheet-richmicrocapsules using eADF-4
via a process of spontaneous assembly at a toluene/water interface
in water-in-toluene emulsions. The mechanically and chemically
stable microcapsules can be transferred into aqueous solution
either via centrifugation into an aqueous sub-layer, or dilution of
the toluene by addition of an excess of ethanol and water (see
Fig. 8) [277,278].
We have demonstrated that these microcapsules are capable of
encapsulation of model macromolecular drugs (such as FITC-
labelled dextran) whilst allowing small molecules (such as ﬂuo-
rescein) to diffuse freely across the membrane. The capsules can be
degraded upon exposure to Proteinase K in amatter of minutes (see
Fig. 9), moreover, this degradation can be prevented by chemical
cross-linking of the microcapsules via photo-initiated oxidation
with ammonium peroxodisulfate and tris(2,20-bipyridyl)di-
chlororuthenium(II) [277,278].
3.7. Solid supports for catalysts
Silk protein-based materials have found application as solid
supports for potentially expensive enzyme and organometallic
catalysts.
Silk proteins are capable of forming functional complexes with
metal ions. One potential application of the metal complexes is in
the immobilization of catalysts, the ﬁrst example of which was a B.
mori ﬁbroin–palladium catalyst capable of asymmetric hydroge-
nations. These heterogeneous catalysts were used to prepareWATER
dried material
TOLUENE
WATER
ADF-4 (red) and drug (green) is emulsiﬁed in toluene leading to spontaneous assembly
at can subsequently be transferred into aqueous solution. Bottom: an aqueous solution
te leading to liquid–liquid phase separation of a protein-rich phase in a protein-poor
crospheres.
light microscopy
0 min 5 min 13 minProteinase K digestion
2 µm
fluorescence 
microscopy
Fig. 9. Proteinase K digestion of spider silk microcapsules encapsulating FITC-labelled dextran, indicating the release of the encapsulated FITC-labelled dextran.
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diamine, glutamic acid and phenylalanine. The preparation, prop-
erties, selectivity, stability and structure of these palladium based
catalysts were subsequently investigated in more detail [355–357],
as were the platinum [358,359] and rhodium analogues [360].
More recently it has also been demonstrated that B. mori ﬁbroin–
palladium catalysts are capable of highly chemoselective hydroge-
nation of acetylenes, oleﬁns and azides in the presence of other
groups that are readily hydrogenated using Pd/C or Pd/C(en) as
a catalyst (such as aromatic aldehydes and ketones, halides, and
benzylesterandN-Cbzprotectinggroups) [361–364].B.moriﬁbroin–
iron catalysts are capable of hydroxylation of phenol to catechol and
hydroquinone. The catalyst had a slight selectivity for catechol overprotein
1st step: labeling
1st step: film formation
NH2
COOH
NH2
unmodified 
film
Fig. 10. Schematic of ﬁlm formation and labeling, and phydroquinone, and could be recovered and reused several times
without a signiﬁcant decrease in its activity [365]. B. mori ﬁbroin–
metallophthalocyanine catalysts are capable of theeliminationof the
malodors of hydrogen sulﬁde and methane thiol via catalytic
oxidation, and may ﬁnd application in air puriﬁcation [366,367].
Enzymes can be effectively immobilized via covalently linking
the silk protein to the enzyme using well established azide, cyan-
ogen bromide, diazo or glutaraldehyde methodologies. Aspartate
aminotransferase, calf intestine alkaline phosphatase, and ribonu-
clease have been covalently attached to B. mori ﬁbroin ﬁbers using
such methodologies and were shown to maintain their activity
[368–371]. Enzymes may also be effectively immobilized via
physical entrapment within silk ﬁlms. Films are typically cast from= chemical molecule
2nd  step: film formation
COOH
2nd step: labeling
film with 
immobilized
enzyme
hotographs of examples of such ﬁlms from our lab.
nonwoven
Araneus 
diadematus
hydrogel
filmfoam
capsule sphere
thread
Fig. 11. The various morphologies that can be prepared with a single recombinantly produced engineered spider silk protein eADF-4.
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b-sheet formation is induced in order to immobilize the enzyme.
B. mori ﬁbroin–glucose oxidase ﬁlms were demonstrated to be
excellent glucose sensors in terms of enzyme leakage, response time
and storage stability [250,372,373]. B. mori ﬁbroin–horseradish
peroxidaseﬁlmswere shown tobe excellent biophotosensors for the
chemiluminescent detection of hydrogen peroxide by the luminol
reaction catalyzed by the immobilized peroxidase [351,374].
We have prepared mechanically stable b-sheet-rich ﬁlms
of eADF-4 displaying active enzymes such as b-galactosidase on
their surface, and demonstrated their activity using 5-bromo-4-
chloro-3-indolyl-b-D-galactopyranoside as a substrate (see Fig. 10)
[258–261].3.8. Materials with novel electronic, magnetic and optical
properties via the encapsulation of colloidal and nanoscale particles
Naturally spun major ampullate silk ﬁbers produced by N. edulis
spiders can be coated in nanoparticles (via dip-coating in suspen-
sions of nanoparticles and air-drying) with almost no detrimental
effect upon the mechanical properties of the ﬁbers. Coating the
ﬁbers in superparamagnetic magnetite (Fe3O4) allowed the orien-
tation of the ﬁbers in a magnetic ﬁeld, potentially allowing inte-
gration into devices for audio reproduction. It is also possible to
form stable coatings of electroconducting polypyrrole, semi-
conducting cadmium sulﬁde particles and hydrophobically func-
tionalized gold nanoparticles [312].
Hollow mesoporous silica ﬁbers can be prepared via coating
forcibly silked major ampullate silk ﬁbers (produced by Nephila
madagascariensis spiders) with a silica-surfactant mesophase, and
subsequently removing the silk andsurfactantvia calcinations [375].
Hollowporous silica ﬁbers can be preparedbycoatingB.moriﬁbroin
ﬁberswith tetraethylorthosilicate (a silica precursor) in supercritical
CO2. The silica coating faithfully reproduced the surface features of
the B. mori silk ﬁbers and it was possible to tune the diameter, wall
thickness and porous structure of the silica ﬁbers by varying the
processing parameters [376]. Such hollow porous ﬁbers may ﬁndapplication as host materials for a variety of electrically or optically
active chemical species [375], as was demonstrated with porous
ﬁbers of titania and zirconia containing gold nanoparticles [377].
B. mori ﬁbroin micelles have been used as an active scaffold for
growing gold/ﬁbroin core/shell particles via reduction of Au(III) to
Au(0) in the presence of ﬁbroin. The coreswere 3–20 nm in size and
the core/shell particles were stable for months at room tempera-
ture, and may be useful in a variety of nanotechnological applica-
tions [378]. Spider silk ﬁbers harvested from the webs produced by
Pholcus phalangioides spiders have been used as an active scaffold
uponwhich to grow gold nanoparticles, via reaction of the silk ﬁber
with aqueous chloroauric acid. Solvent vapor induced structural
changes in the ﬁbers, thereby altering their electrical properties,
and these materials may ﬁnd application as vapor sensors [379].
Green ﬂuorescent protein (GFP) is commonly linked to other
proteins as a ﬂuorescent tag to determine location of the other
protein in microscope-based studies of biological systems. GFP also
has interesting nonlinear optical properties, such as levels of two-
photon absorption that are high enough to saturate the two-photon
transition probability under certain conditions. This creates a
population inversion in the chromophore, giving GFP potential
application in laser technology [380,381]. Films may be cast from
aqueous solutions of B. mori ﬁbroin and GFP with a sufﬁcient
density of GFP molecules for two-photon absorption and potential
application in photonics [382,383].4. Summary and outlook
Silk proteins can be processed into a diverse set of morphologies
with a great potential for various applications. We envisage that in
the future, proteins in general will be employed in addition to, and
in some cases in place of classical synthetic polymers. Bio-
technologically produced silk proteins will allow the preparation of
a new generation of protein-based biopolymeric materials with
programmed properties for a wide variety of exciting applications
(Fig. 11).
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